Which hedge funds own ARQT? ARCUTIS BIOTHERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in ARQT (ARCUTIS BIOTHERAPEUTICS INC) in their Q2 2026 13F filings, worth $727.4m in total. The largest holder by portfolio weight is Suvretta Capital Management at 6.9% of its book. 2 managers opened a new position this quarter: Tudor Investment, Holocene Advisors. 1 exited: Farallon Capital Management.
11tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold ARQT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 6.9% | $326.1m | 12,437,000 | 1% | added |
| Rubric Capital Management | Q2 2026 | 2.0% | $216.9m | 8,271,577 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $103.6m | 3,949,609 | 58% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $30.4m | 1,160,014 | 7333% | added |
| Woodline Partners | Q2 2026 | 0.0% | $5.1m | 195,033 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $9.5m | 362,449 | -39% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $3.5m | 131,914 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $14.8m | 564,072 | 1043% | added |
| Marshall Wace | Q2 2026 | 0.0% | $11.7m | 446,866 | -82% | reduced |
| Holocene Advisors | Q2 2026 | 0.0% | $4.3m | 163,732 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.5m | 58,399 | -87% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $612.6k |
How has hedge fund ownership of ARQT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $727.4m |
| Q1 2026 | 10 | $632.5m |
| Q4 2025 | 7 | $617.4m |
| Q3 2025 | 6 | $411.9m |
| Q2 2025 | 6 | $340.3m |
| Q1 2025 | 7 | $371.9m |
| Q4 2024 | 6 | $337.4m |
| Q3 2024 | 7 | $206.4m |
| Q2 2024 | 4 | $184.8m |
| Q1 2024 | 5 | $172.4m |
| Q4 2023 | 4 | $51.1m |
| Q3 2023 | 5 | $45.3m |
| Q2 2023 | 4 | $76.3m |
| Q1 2023 | 6 | $94.6m |
| Q4 2022 | 5 | $109.4m |
| Q3 2022 | 7 | $111.3m |
Counts every tracked manager that disclosed ARQT in that quarter's filing, including managers that have since stopped filing.